siRNA
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1 (NCT03350451) | Alnylam Pharmaceuticals | 2018-04-04 |
Track siRNA automatically
Every clearance here is in the API, with alerts when new ones post.